One possible explanation is that the activation of the MAPK signalling pathway caused by BRAF increase promotes tumor cell growth and proliferation [17, 18], thereby influencing melanoma progression from AJCC Stage I to Stage II. This evidence concerns the gene BRAF and melanoma.